Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-30 @ 11:24 PM
Study NCT ID:
NCT01380769
Status:
COMPLETED
Last Update Posted:
2020-05-28
First Post:
2011-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
NewLink Genetics Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-22
First Submit QC Date:
None
Study First Post Date:
2011-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-26
Results First Submit QC Date:
None
Results First Post Date:
2017-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-26
Last Update Post Date:
2020-05-28
Last Update Post Date Type:
ACTUAL